Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Dec 7, 2023; 29(45): 5953-5961
Published online Dec 7, 2023. doi: 10.3748/wjg.v29.i45.5953
Table 1 Demographic, irritable bowel syndrome and war exposure summary
Variable
Total
Gender
P value1
Age group
P value1
N (%)
Men, n (%)
Women, n (%)
29-39, n (%)
40-49, n (%)
50-65, n (%)
Poverty0.1750.0102
    Non-poor657 (64.9)229 (62.2)428 (66.5)227 (59.6)224 (65.9)206 (70.8)
    Poor/extremely poor355 (35.1)139 (37.8)216 (33.5)154 (40.4)116 (34.1)85 (29.1)
Educational level0.933< 0.0012
    Primary school489 (48.3)175314 (48.8)117 (30.7)163 (47.8)209 (71.8)
    High school372 (36.8)(47.6)
137
235 (36.5)183 (48.0)124 (36.5)65 (22.3)
    Professional151 (14.9)(37.2)
56 (15.2)
95 (14.7)81 (21.2)53 (15.6)17 (5.8)
IBS0.02920.593
    No858 (84.8)324 (88.0)534 (82.9)320 (84.0)286 (84.1)252 (86.6)
    Yes154 (15.2)44 (12.0)110 (17.1)61 (16.0)54 (15.9)39 (13.4)
PTSD0.1800.537
    No955 (94.4)352 (95.7)603 (93.6)362 (95.0)317 (93.2)276 (94.8)
    Yes57 (5.6)16 (4.3)41 (6.4)19 (5.0)23 (6.8)15 (5.2)
War< 0.00120.0222
    No817 (80.7)233 (63.3)584 (90.7)321 (84.3)259 (76.2)237 (81.4)
    Yes195 (19.3)135 (36.7)60 (9.3)60 (15.7)81 (23.8)54 (18.6)
PTSD + War0.4220.095
    No987 (97.0)357 (97.0)630 (97.8)376 (98.7)327 (96.2)284 (97.6)
    Yes25 (3.0)11 (3.0)14 (2.2)5 (1.3)13 (3.8)7 (2.4)
Dose Effect< 0.00120.199
    0-2 exposures945 (93.4)308 (83.7)637 (98.9)358 (94.0)311 (91.5)276 (94.8)
    ≥ 3 exposures67 (6.6)60 (16.3)7 (1.1)23 (6.0)29 (8.5)15 (5.2)
Total1012 (100.0)368 (100.0)644 (100.0)381 (100.0)340 (100.0)291 (100.0)
Table 2 Irritable bowel syndrome prevalence by Rome II criteria among 1012 study participants
Variables
IBS
P value1
N (%)
95%CI
Gender0.0292
    Male44 (12.0)9.0–15.7
    Female110 (17.1)14.4–20.2
Age group0.593
    29-3961 (16.0)12.7-20.0
    40-4954 (15.9)12.4-20.1
    ≥ 5039 (13.4)9.9-17.8
Socioeconomic status30.298
    Non-poor97 (14.8)12.3-17.7
    Poor/Extremely poor57 (16.1)12.6-20.24
Educational level0.701
    Primary school/Lower70 (14.3)11.5-17.7
    High school61 (16.4)13.0-20.5
    University/Professional23 (15.2)10.4-21.8
War0.237
    No119 (14.6)12.3-17.1
    Yes35 (17.9)13.2-23.9
Table 3 Association between Irritable bowel syndrome and specific war exposures
Condition
IBS, n (%)
Non-IBS, n (%)
Unadjusted1, OR (95%CI)
Adjusted2, OR (95%CI)
Direct Exposures
War experience35 (22.7)160 (18.6)1.28 (0.84-1.94)1.30 (0.81-2.09)
Direct combat involvement13 (8.4)77 (9.0)0.93 (0.50-1.72)0.61 (0.27-1.38)
Abuse, physical or psychological317 (11.0)47 (5.5)2.19 (1.19-3.83)2.25 (1.12-4.49)
Witnessed execution317 (11.0)51 (5.9)1.96 (1.10-3.50)2.41 (1.11-5.23)
Physical injury or disability3 (1.9)8 (0.9)2.11 (0.55-8.04)1.29 (0.27-6.02)
Indirect Exposures
Death of a family member320 (13.0)68 (7.9)1.73 (1.01-2.94)2.21 (1.17-4.17)
Family member wounded9 (5.8)42 (4.9)1.20 (0.57-2.53)0.80 (0.33-1.93)
Post-war effects
Loss of personal property3 (1.9)19 (2.2)0.87 (0.25-3.00)0.86 (0.24-3.08)
Rejection by family5 (3.2)16 (1.9)2.58 (0.88-7.54)2.57 (0.82-8.07)
Unemployment9 (5.8)36 (4.2)1.41 (0.66-3.00)1.58 (0.69-3.65)
Dose effect
≥ 3 exposures316 (10.4)67 (7.8)1.83 (1.01-3.30)2.67 (1.39-5.13)
PTSD
PTSD324 (15.6)33 (3.8)4.61 (2.64-8.05)2.63 (1.21-5.73)
PTSD, war associated314 (9.1)11 (1.3)7.70 (3.42-17.3)3.31 (1.09-10.0)